首页 > 最新文献

Engineered regeneration最新文献

英文 中文
Q1 Medicine Pub Date : 2025-01-01
{"title":"","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":72919,"journal":{"name":"Engineered regeneration","volume":"6 ","pages":"Pages 188-202"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146543268","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Q1 Medicine Pub Date : 2025-01-01
{"title":"","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":72919,"journal":{"name":"Engineered regeneration","volume":"6 ","pages":"Pages 1-16"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146543282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Q1 Medicine Pub Date : 2025-01-01
{"title":"","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":72919,"journal":{"name":"Engineered regeneration","volume":"6 ","pages":"Pages 235-248"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146543286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Q1 Medicine Pub Date : 2025-01-01
{"title":"","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":72919,"journal":{"name":"Engineered regeneration","volume":"6 1","pages":"Pages 188-202"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146836183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Q1 Medicine Pub Date : 2025-01-01
{"title":"","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":72919,"journal":{"name":"Engineered regeneration","volume":"6 1","pages":"Pages 54-73"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146836192","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Q1 Medicine Pub Date : 2025-01-01
{"title":"","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":72919,"journal":{"name":"Engineered regeneration","volume":"6 1","pages":"Pages 146-159"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146836201","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bioactive scaffolds integrated with micro-precise spatiotemporal delivery and in vivo degradation tracking for complex tissue regeneration 生物活性支架集成微精确时空传递和体内降解跟踪复杂组织再生
Q1 Medicine Pub Date : 2025-01-01 DOI: 10.1016/j.engreg.2025.01.001
Hun Jin Jeong, Alia Koch, Soomin Park, Solaiman Tarafder, Chang H. Lee
Three-dimensional (3D) printing has evolved to incorporate controlled delivery systems to guide the regeneration of complex tissues, with limited clinical translation. The challenges include the limited precision in spatiotemporal delivery and poorly understood in vivo scaffold degradation rates. Here, we report auspicious preclinical outcomes in the functional regeneration of temporomandibular joint (TMJ) discs of mini-pigs. TMJ disc has been an extremely challenging target for regenerative engineering given the uniquely heterogeneous matrix distribution and region-variant anisotropic orientation. We optimally implemented advanced 3D printing technologies with micro-precise spatiotemporal delivery to build anatomically correct, bioactive scaffolds with native-like regionally variant microstructure and mechanical properties. We also applied quantum dots (QDs) labeling of scaffolds to enable non-invasive in vivo degradation tracking. In mini-pigs, the scaffold implantation upon discectomy has successfully led to in-situ regeneration of TMJ discs by 3 months, exhibiting native-like heterogeneity and multi-scale mechanical properties without any sign of cartilage damage. In addition, our non-invasive imaging resulted in reliable in vivo tracking of scaffold degradation, exhibiting notably different degradation rates between individual animals. Our findings suggest a significant translational potential of our cell-free, bioactive scaffolds equipped with non-invasive tracking modality for in-situ tissue engineering of TMJ discs.
三维(3D)打印已经发展到结合控制输送系统来指导复杂组织的再生,但临床翻译有限。挑战包括有限的时空递送精度和对体内支架降解率的了解不足。在这里,我们报告了迷你猪颞下颌关节(TMJ)椎间盘功能再生的临床前结果。由于其独特的非均质矩阵分布和区域各向异性取向,TMJ椎间盘一直是再生工程中极具挑战性的目标。我们优化了先进的3D打印技术,通过微精确的时空传递来构建解剖学上正确的、具有生物活性的支架,这些支架具有类似于天然区域变化的微观结构和机械性能。我们还应用量子点(QDs)标记支架来实现无创体内降解跟踪。在小型猪中,椎间盘切除术后支架植入成功地导致TMJ椎间盘原位再生3个月,表现出类似天然的异质性和多尺度力学性能,没有任何软骨损伤的迹象。此外,我们的非侵入性成像导致了可靠的支架降解的体内跟踪,显示出个体动物之间明显不同的降解率。我们的研究结果表明,我们的无细胞、生物活性支架具有非侵入性跟踪模式,在TMJ椎间盘原位组织工程中具有重要的转化潜力。
{"title":"Bioactive scaffolds integrated with micro-precise spatiotemporal delivery and in vivo degradation tracking for complex tissue regeneration","authors":"Hun Jin Jeong,&nbsp;Alia Koch,&nbsp;Soomin Park,&nbsp;Solaiman Tarafder,&nbsp;Chang H. Lee","doi":"10.1016/j.engreg.2025.01.001","DOIUrl":"10.1016/j.engreg.2025.01.001","url":null,"abstract":"<div><div>Three-dimensional (3D) printing has evolved to incorporate controlled delivery systems to guide the regeneration of complex tissues, with limited clinical translation. The challenges include the limited precision in spatiotemporal delivery and poorly understood <em>in vivo</em> scaffold degradation rates. Here, we report auspicious preclinical outcomes in the functional regeneration of temporomandibular joint (TMJ) discs of mini-pigs. TMJ disc has been an extremely challenging target for regenerative engineering given the uniquely heterogeneous matrix distribution and region-variant anisotropic orientation. We optimally implemented advanced 3D printing technologies with micro-precise spatiotemporal delivery to build anatomically correct, bioactive scaffolds with native-like regionally variant microstructure and mechanical properties. We also applied quantum dots (QDs) labeling of scaffolds to enable non-invasive <em>in vivo</em> degradation tracking. In mini-pigs, the scaffold implantation upon discectomy has successfully led to <em>in-situ</em> regeneration of TMJ discs by 3 months, exhibiting native-like heterogeneity and multi-scale mechanical properties without any sign of cartilage damage. In addition, our non-invasive imaging resulted in reliable <em>in vivo</em> tracking of scaffold degradation, exhibiting notably different degradation rates between individual animals. Our findings suggest a significant translational potential of our cell-free, bioactive scaffolds equipped with non-invasive tracking modality for in-situ tissue engineering of TMJ discs.</div></div>","PeriodicalId":72919,"journal":{"name":"Engineered regeneration","volume":"6 ","pages":"Pages 34-44"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143631885","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel microsphere scaffold-based islet organoids for rescuing type 1 diabetes and reversing hyperglycemia 新型微球支架胰岛类器官用于治疗1型糖尿病和逆转高血糖
Q1 Medicine Pub Date : 2025-01-01 DOI: 10.1016/j.engreg.2025.05.001
Yanan Jing , Guidan Wang , Ruolin Shi , Wenjing Wen , Wenjie Wang , Xuan Zhao , Gaofeng Liang
Type 1 diabetes (T1D) is an autoimmune deficiency disease characterized by elevated blood sugar levels and insulin resistance, leading to various adverse health effects and complications, such as diabetic cardiomyopathy and diabetic ketoacidosis. Currently, T1D is primarily treated through organoid transplantation and extracorporeal insulin injection. However, the clinical utility of these treatments is limited by increased systemic immunosuppression due to graft donor shortages and the side effects associated with exogenous insulin therapy. Recently, the emergence of bioengineered islet-like organs has opened up possibilities for constructing insulin-secreting cells in vitro to treat insulin-dependent diabetes. In this study, we developed a novel microsphere scaffold-based islet cell spheroid culture system that integrates islet organoids with 3D microsphere scaffolds, enabling the consistent generation of 3D islet cell spheroids. Following transplantation into the renal capsule of diabetic mice, these organoids demonstrated significant hypoglycemic effects, with detectable insulin secretion in the serum. On day 30 post-transplantation, β-cell marker expression was significantly increased in the grafts. We further investigated the glucose-related proteins that microsphere scaffold-based islet organoids may regulate. Our findings confirm that islet-like organoids can effectively secrete insulin and play a role in maintaining blood sugar stability. These results indicate that islet-like organs generated via microsphere scaffolds exhibit similar endocrine functions to those of natural islets, can survive in the host body for extended periods, and can effectively exert hypoglycemic effects, thereby providing a solid foundation for the application of islet-like organs in type 1 diabetes research.
1型糖尿病(T1D)是一种以血糖水平升高和胰岛素抵抗为特征的自身免疫性缺陷疾病,可导致各种不良健康影响和并发症,如糖尿病性心肌病和糖尿病酮症酸中毒。目前,T1D主要通过类器官移植和体外胰岛素注射治疗。然而,由于移植物供体短缺和外源性胰岛素治疗相关的副作用,这些治疗的临床应用受到全身免疫抑制增加的限制。最近,生物工程胰岛样器官的出现为体外构建胰岛素分泌细胞治疗胰岛素依赖型糖尿病开辟了可能性。在本研究中,我们开发了一种新型的基于微球支架的胰岛细胞球体培养系统,该系统将胰岛类器官与3D微球支架结合在一起,使3D胰岛细胞球体能够一致生成。移植到糖尿病小鼠的肾囊后,这些类器官显示出显著的降糖作用,血清中可检测到胰岛素分泌。移植后第30天,移植物中β细胞标记物的表达显著增加。我们进一步研究了基于微球支架的胰岛类器官可能调节的葡萄糖相关蛋白。我们的研究结果证实,类胰岛器官可以有效地分泌胰岛素,并在维持血糖稳定中发挥作用。这些结果表明,通过微球支架制备的胰岛样器官具有与天然胰岛相似的内分泌功能,可在宿主体内存活较长时间,并能有效发挥降糖作用,从而为胰岛样器官在1型糖尿病研究中的应用提供了坚实的基础。
{"title":"Novel microsphere scaffold-based islet organoids for rescuing type 1 diabetes and reversing hyperglycemia","authors":"Yanan Jing ,&nbsp;Guidan Wang ,&nbsp;Ruolin Shi ,&nbsp;Wenjing Wen ,&nbsp;Wenjie Wang ,&nbsp;Xuan Zhao ,&nbsp;Gaofeng Liang","doi":"10.1016/j.engreg.2025.05.001","DOIUrl":"10.1016/j.engreg.2025.05.001","url":null,"abstract":"<div><div>Type 1 diabetes (T1D) is an autoimmune deficiency disease characterized by elevated blood sugar levels and insulin resistance, leading to various adverse health effects and complications, such as diabetic cardiomyopathy and diabetic ketoacidosis. Currently, T1D is primarily treated through organoid transplantation and extracorporeal insulin injection. However, the clinical utility of these treatments is limited by increased systemic immunosuppression due to graft donor shortages and the side effects associated with exogenous insulin therapy. Recently, the emergence of bioengineered islet-like organs has opened up possibilities for constructing insulin-secreting cells in vitro to treat insulin-dependent diabetes. In this study, we developed a novel microsphere scaffold-based islet cell spheroid culture system that integrates islet organoids with 3D microsphere scaffolds, enabling the consistent generation of 3D islet cell spheroids. Following transplantation into the renal capsule of diabetic mice, these organoids demonstrated significant hypoglycemic effects, with detectable insulin secretion in the serum. On day 30 post-transplantation, β-cell marker expression was significantly increased in the grafts. We further investigated the glucose-related proteins that microsphere scaffold-based islet organoids may regulate. Our findings confirm that islet-like organoids can effectively secrete insulin and play a role in maintaining blood sugar stability. These results indicate that islet-like organs generated via microsphere scaffolds exhibit similar endocrine functions to those of natural islets, can survive in the host body for extended periods, and can effectively exert hypoglycemic effects, thereby providing a solid foundation for the application of islet-like organs in type 1 diabetes research.</div></div>","PeriodicalId":72919,"journal":{"name":"Engineered regeneration","volume":"6 ","pages":"Pages 121-132"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144271984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Q1 Medicine Pub Date : 2025-01-01
{"title":"","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":72919,"journal":{"name":"Engineered regeneration","volume":"6 ","pages":"Pages 133-145"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146543270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Q1 Medicine Pub Date : 2025-01-01
{"title":"","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":72919,"journal":{"name":"Engineered regeneration","volume":"6 ","pages":"Pages 174-187"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146543283","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Engineered regeneration
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1